Study details
Enrolling now
Enhanced Recovery After Surgery in Extremity Sarcoma Trial
Joshua Lawrenz
NCT IDNCT04461171ClinicalTrials.gov data as of Apr 2026
Target enrollment
120
Study length
about 5.5 years
Ages
18+
Locations
1 site in TN
What this study is about
Researchers are testing whether an enhanced recovery after surgery (ERAS) pathway improves outcomes for adults undergoing surgery to treat extremity sarcoma. The trial will last approximately 20 months and involve about 120 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Undergo Enhanced Recovery After Surgery
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Pain scores
Procedures
surgery